NASDAQ Companies

Presentations highlight data supporting FILSPARI®(sparsentan) as a foundational therapy over historical RASi standard of care and in newly diagnosed patients […]

Selected Highlights First quarter Operating EBITDA* of $63.6 million and net loss of $16.7 million Improving pulp markets and lower […]

Montrouge, France, May 9, 2024 DBV Technologies to Participate in Upcoming Investor Conferences DBV Technologies (Euronext: DBV – ISIN: FR0010417345 […]

HOUSTON, May 09, 2024 (GLOBE NEWSWIRE) — U.S. Energy Corporation (NASDAQ: USEG, “U.S. Energy” or the “Company”), a growth-focused energy […]

Advancing TPST-1120 into a pivotal Phase 3 trial in first-line HCC and TPST-1495 into a Phase 2 in FAP Reported […]

WESTLAKE VILLAGE, Calif., May 09, 2024 (GLOBE NEWSWIRE) — Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced […]

MINNEAPOLIS, May 09, 2024 (GLOBE NEWSWIRE) — Jamf (NASDAQ: JAMF), the standard in managing and securing Apple at work, announced […]

Product Sales up a robust 14% over prior year, and a significant 22% sequentially We believe the STAR-T data presented […]

Strong performance versus guidance Total operating expenses declined 15% sequentially and 25% year-over-year GAAP net loss sharply reduced by $76M […]

First Quarter 2024: Revenue down 40% from Q1 2023 Gross profit down 40% from Q1 2023 Operating Expenses down 31% […]